Dr. Schulz is a professor and Director of the Memory Disorders and Dementia Clinic in the Department of Neurology at McGovern Medical School at UTHealth Houston. He is fellowship trained in cellular neurophysiology.
A UTHealth Neurosciences physician affiliated with Mischer Neuroscience Institute, he is currently investigating risk factors for dementia and is utilizing Aduhelm™ (aducanumab-avwa), the promising new treatment option for Alzheimer’s disease, in his patients’ treatment plans, when appropriate.
Dr. Schulz will discuss Aduhelm™, the newest Alzheimer’s disease drug in over 20 years.
During the webinar, you will learn more about:
During the webinar, you will get answers relating to:
Please fill out the fields below, and we will contact you.